Green tea has real research behind it. But the research was on the beverage, not the capsule. Here's where it fits, and why the pill isn't the version to reach for.
Russell W. Raskin, MD · Board-Certified Emergency Medicine & Internal Medicine · R.W. Raskin Health Protocols, LLC
That difference is the whole point. Brewed green tea and a concentrated green tea extract in a capsule are not the same thing, and the research that looks so good was done on the cup, not the pill. Here's where green tea fits when you're sick, and why the capsule is the wrong version.
Green tea as a beverage is one thing. A concentrated green tea extract in a capsule is another. The research worth taking seriously was done on brewed green tea, not on an isolated extract. Something in that cup appears to reduce respiratory infection risk. The leading explanation points to a family of compounds called catechins, particularly one known as EGCG. But brewed green tea contains hundreds of compounds: polyphenols, flavonoids, theanine, minerals. No one has cleanly isolated a single ingredient as the responsible agent in human trials. The catechin explanation is compelling. It is also still a hypothesis.
The supplement industry took that hypothesis, concentrated one compound into extract form, and built a product around it. In doing so, it introduced a risk the beverage never had. In rare cases, concentrated green tea extract has caused serious liver injury. There is no test that tells you in advance whether you're one of the vulnerable ones. When a real risk can't be screened for, that ingredient doesn't belong in a daily capsule, even when the beverage it came from has meaningful research behind it. Evidence of benefit does not cancel out a risk you can't see coming.
So where does green tea fit?
Two places. First, brew it regularly, as an ordinary part of your week. One cup daily is a reasonable floor, and the evidence suggests more may do more. A little honey to sweeten it is fine.
Second, when you do get sick, green tea becomes your hot liquid of choice for sore throat and cough. Add honey at that point, for taste and to soothe a scratchy throat.
The research studied a beverage. Following the evidence means drinking the brew, not swallowing a concentrated version of one compound extracted from it.
The Principle
Before you add anything to your daily routine, hold it to a simple standard: possible benefit, with little to no risk. Green tea in a cup clears that bar. The extract doesn't, because the risk isn't small and you can't see it coming.
Green tea earns its place. In a cup, not in a capsule.
Want to go deeper?
The clinician version isn't just for doctors. It's the same topic, written for physicians — the full reasoning, nothing simplified. You're allowed to read it. Read the clinician version →
Clinician Guide — Peer to Peer · Russell W. Raskin, MD
It's in the Cup
The evidence was for the beverage. The industry sold the extract. The distinction matters.
Russell W. Raskin, MD · Board-Certified Emergency Medicine & Internal Medicine · R.W. Raskin Health Protocols, LLC
The distinction is not pedantic. The prevention signal was built on brewed green tea and dietary catechin intake. The product on the shelf is a concentrated extract, and it carries a risk the beverage does not. What follows is the evidence for the beverage, the case against the extract, and what to tell patients who ask.
This rests on the largest evidence base available: 107 randomized controlled trials, 101,751 adults (Zhu et al., EClinicalMedicine, 2025). Across that body of trials, catechins ranked among the most effective interventions for reducing respiratory infection incidence: relative risk 0.79, 95% CI 0.66 to 0.95, high certainty. That's a meaningful signal. But where the evidence comes from matters as much as the number.
The studies were conducted on brewed green tea consumption and dietary catechin intake, not on isolated EGCG extract. Brewed green tea contains hundreds of bioactive compounds. The catechin hypothesis is the leading mechanistic explanation, supported by in vitro and animal data in which EGCG is believed to inhibit viral binding, block RNA polymerase activity, and enhance mucosal IgA production. But no human RCT has cleanly isolated EGCG as the sole responsible agent. The industry took a beverage association, attributed it to one compound, concentrated that compound, and built a product, without establishing that the extract performs the way the beverage does and without the safety record the beverage has accumulated over centuries. Concentrating one compound out of that cup was a hypothesis, not a proof.
It also introduced a risk the beverage never carried. The Drug-Induced Liver Injury Network registry documents idiosyncratic immune-mediated hepatotoxicity from concentrated green tea extract. The HLA-B*35:01 association is recognized by AASLD, and it is present in 72% of green tea extract hepatotoxicity cases, consistent with an immune-mediated mechanism. The allele can be typed. No HLA screening exists anywhere in consumer supplement use. In a real-world direct-to-consumer population there is no practical way to identify a vulnerable buyer before injury occurs. EFSA has identified doses at or above 800 mg EGCG per day in supplement form as associated with statistically significant transaminase elevations.
So the extract rests on an unproven extraction hypothesis and carries an unscreenable hepatotoxicity signal in exactly the population that buys it. Benefit that can't be separated from a risk you can't screen for is not a benefit you can responsibly hand a patient in capsule form.
What to tell patients
Recommend the form the evidence was actually built on: brewed green tea, a minimum of one cup daily as an ordinary habit, and the hot liquid of choice during acute illness, with honey. The benefit appears to track with intake. One cup daily is the floor, and a second may add to it. Whatever in that cup does the work is present. The hepatotoxicity signal is not.
Worth naming, since patients ask: the beverage is well tolerated at ordinary intake but it isn't inert. Caffeine can matter in caffeine-sensitive patients or those prone to sleep disruption, and tea polyphenols reduce non-heme iron absorption from a meal taken alongside them, though longer-term data have not shown a corresponding effect on iron status. Neither is a reason to avoid it. The risk is small, but it isn't zero.
Clinical Bottom Line
Strong prevention signal in the beverage. Unproven extraction hypothesis in the capsule. Unscreenable hepatotoxicity in the extract. Recommend brewed green tea, not concentrated extract. It's the form the evidence was actually built on.
For the exam room
The patient version is the plain-language take on the same topic — no jargon, no prescription pad. Built to hand a patient after the visit, so the conversation keeps going after they leave.
Zhu Z, Zhu X, Chu Y, Zhang B, Chen Y. Comparative Effectiveness of Oral Nutritional Supplements in Preventing Respiratory Tract Infections Among Adults: A Systematic Review and Network Meta-Analysis. EClinicalMedicine. 2025;88:103479.
Fontana RJ, Liou I, Reuben A, et al. AASLD Practice Guidance on Drug, Herbal, and Dietary Supplement-Induced Liver Injury. Hepatology. 2023;77(3):1036–1065.
Hoofnagle JH, Bonkovsky HL, Phillips EJ, et al. HLA-B*35:01 and Green Tea-Induced Liver Injury. Hepatology. 2021;73(6):2484–2493.
Younes M, Aggett P, Aguilar F, et al. Scientific Opinion on the Safety of Green Tea Catechins. EFSA Journal. 2018;16(4):e05239.
Umeda M, Tominaga T, Kozuma K, et al. Preventive Effects of Tea and Tea Catechins Against Influenza and Acute Upper Respiratory Tract Infections: A Systematic Review and Meta-Analysis. European Journal of Nutrition. 2021;60(8):4189–4202.
Park M, Yamada H, Matsushita K, et al. Green Tea Consumption Is Inversely Associated With the Incidence of Influenza Infection Among Schoolchildren in a Tea Plantation Area of Japan. J Nutr. 2011;141(10):1862–1870.
Delimont NM, Haub MD, Lindshield BL. The Impact of Tannin Consumption on Iron Bioavailability and Status: A Narrative Review. Curr Dev Nutr. 2017;1(2):1–12.
The evidence was for the beverage. The industry sold the extract. Follow the evidence — to the cup.